- Home
- BCLI vs ADN Comparison
BCLI vs ADN Comparison
Compare BCLI & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- ADN
- Stock Information
- Founded
- BCLI 2000
- ADN 2006
- Country
- BCLI United States
- ADN United States
- Employees
- BCLI N/A
- ADN N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- ADN Power Generation
- Sector
- BCLI Health Care
- ADN Utilities
- Exchange
- BCLI Nasdaq
- ADN Nasdaq
- Market Cap
- BCLI 9.1M
- ADN 8.5M
- IPO Year
- BCLI N/A
- ADN N/A
- Fundamental
- Price
- BCLI $2.25
- ADN $5.00
- Analyst Decision
- BCLI Strong Buy
- ADN
- Analyst Count
- BCLI 1
- ADN 0
- Target Price
- BCLI $30.00
- ADN N/A
- AVG Volume (30 Days)
- BCLI 112.8K
- ADN 62.8K
- Earning Date
- BCLI 11-14-2024
- ADN 10-15-2024
- Dividend Yield
- BCLI N/A
- ADN N/A
- EPS Growth
- BCLI N/A
- ADN N/A
- EPS
- BCLI N/A
- ADN N/A
- Revenue
- BCLI N/A
- ADN $7,026,000.00
- Revenue This Year
- BCLI N/A
- ADN $2,232.99
- Revenue Next Year
- BCLI N/A
- ADN $91.56
- P/E Ratio
- BCLI N/A
- ADN N/A
- Revenue Growth
- BCLI N/A
- ADN 9.01
- 52 Week Low
- BCLI $1.05
- ADN $1.71
- 52 Week High
- BCLI $11.85
- ADN $10.11
- Technical
- Relative Strength Index (RSI)
- BCLI 70.03
- ADN 45.74
- Support Level
- BCLI $1.45
- ADN $5.79
- Resistance Level
- BCLI $1.72
- ADN $6.77
- Average True Range (ATR)
- BCLI 0.18
- ADN 0.64
- MACD
- BCLI 0.08
- ADN -0.17
- Stochastic Oscillator
- BCLI 84.69
- ADN 34.44
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.